In addition, miRNA sponge for miR-23b can reduce GBM tumor malignancy, through the downregulation of HIF-1α, VEGF, and other molecules, suggesting miR-23 as a promising anticancer therapy either alone or in combination with current targeted therapies [118]. This evidence concerns the gene HIF1A and glioblastoma.